BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33338855)

  • 1. Loss of cellular identity in common pre-clinical models of serine‑threonine kinase 11 (Liver kinase B1) loss.
    Karthikeyan SK; Gimbrone NT; Percy TR; Cress WD
    Cancer Treat Res Commun; 2021; 26():100286. PubMed ID: 33338855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma.
    Zewdu R; Mehrabad EM; Ingram K; Fang P; Gillis KL; Camolotto SA; Orstad G; Jones A; Mendoza MC; Spike BT; Snyder EL
    Elife; 2021 Apr; 10():. PubMed ID: 33821796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer.
    Camolotto SA; Pattabiraman S; Mosbruger TL; Jones A; Belova VK; Orstad G; Streiff M; Salmond L; Stubben C; Kaestner KH; Snyder EL
    Elife; 2018 Nov; 7():. PubMed ID: 30475207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
    Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
    Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
    Caswell DR; Chuang CH; Ma RK; Winters IP; Snyder EL; Winslow MM
    Mol Cancer Res; 2018 Nov; 16(11):1737-1749. PubMed ID: 30002193
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Sitthideatphaiboon P; Galan-Cobo A; Negrao MV; Qu X; Poteete A; Zhang F; Liu DD; Lewis WE; Kemp HN; Lewis J; Rinsurongkawong W; Giri U; Lee JJ; Zhang J; Roth JA; Swisher S; Heymach JV
    Clin Cancer Res; 2021 Mar; 27(6):1720-1733. PubMed ID: 33323404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression and Selective Anticancer Efficacy of
    Park C; Lee Y; Je S; Chang S; Kim N; Jeong E; Yoon S
    Mol Cells; 2019 Nov; 42(11):804-809. PubMed ID: 31697874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription start site-level expression of thyroid transcription factor 1 isoforms in lung adenocarcinoma and its clinicopathological significance.
    Sano K; Hayashi T; Suehara Y; Hosoya M; Takamochi K; Kohsaka S; Kishikawa S; Kishi M; Saito S; Takahashi F; Kaneko K; Suzuki K; Yao T; Ishijima M; Saito T
    J Pathol Clin Res; 2021 Jul; 7(4):361-374. PubMed ID: 34014042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
    Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
    J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment.
    Mollaoglu G; Jones A; Wait SJ; Mukhopadhyay A; Jeong S; Arya R; Camolotto SA; Mosbruger TL; Stubben CJ; Conley CJ; Bhutkar A; Vahrenkamp JM; Berrett KC; Cessna MH; Lane TE; Witt BL; Salama ME; Gertz J; Jones KB; Snyder EL; Oliver TG
    Immunity; 2018 Oct; 49(4):764-779.e9. PubMed ID: 30332632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and
    Koenig MJ; Agana BA; Kaufman JM; Sharpnack MF; Wang WZ; Weigel C; Navarro FCP; Amann JM; Cacciato N; Arasada RR; Gerstein MB; Wysocki VH; Oakes C; Carbone DP
    Cancer Res; 2021 Aug; 81(16):4194-4204. PubMed ID: 34045189
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Skoulidis F; Goldberg ME; Greenawalt DM; Hellmann MD; Awad MM; Gainor JF; Schrock AB; Hartmaier RJ; Trabucco SE; Gay L; Ali SM; Elvin JA; Singal G; Ross JS; Fabrizio D; Szabo PM; Chang H; Sasson A; Srinivasan S; Kirov S; Szustakowski J; Vitazka P; Edwards R; Bufill JA; Sharma N; Ou SI; Peled N; Spigel DR; Rizvi H; Aguilar EJ; Carter BW; Erasmus J; Halpenny DF; Plodkowski AJ; Long NM; Nishino M; Denning WL; Galan-Cobo A; Hamdi H; Hirz T; Tong P; Wang J; Rodriguez-Canales J; Villalobos PA; Parra ER; Kalhor N; Sholl LM; Sauter JL; Jungbluth AA; Mino-Kenudson M; Azimi R; Elamin YY; Zhang J; Leonardi GC; Jiang F; Wong KK; Lee JJ; Papadimitrakopoulou VA; Wistuba II; Miller VA; Frampton GM; Wolchok JD; Shaw AT; Jänne PA; Stephens PJ; Rudin CM; Geese WJ; Albacker LA; Heymach JV
    Cancer Discov; 2018 Jul; 8(7):822-835. PubMed ID: 29773717
    [No Abstract]   [Full Text] [Related]  

  • 13. LKB1 Loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKT.
    Kaufman JM; Amann JM; Park K; Arasada RR; Li H; Shyr Y; Carbone DP
    J Thorac Oncol; 2014 Jun; 9(6):794-804. PubMed ID: 24828662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-testis gene PIWIL1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma.
    Xie K; Zhang K; Kong J; Wang C; Gu Y; Liang C; Jiang T; Qin N; Liu J; Guo X; Huo R; Liu M; Ma H; Dai J; Hu Z
    Cancer Med; 2018 Jan; 7(1):157-166. PubMed ID: 29168346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development and identifies novel HIF-1α regulator.
    Isomura H; Taguchi A; Kajino T; Asai N; Nakatochi M; Kato S; Suzuki K; Yanagisawa K; Suzuki M; Fujishita T; Yamaguchi T; Takahashi M; Takahashi T
    Cancer Sci; 2021 Apr; 112(4):1614-1623. PubMed ID: 33506575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
    Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
    Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
    [No Abstract]   [Full Text] [Related]  

  • 17. ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis.
    Fujiwara T; Hiramatsu M; Isagawa T; Ninomiya H; Inamura K; Ishikawa S; Ushijima M; Matsuura M; Jones MH; Shimane M; Nomura H; Ishikawa Y; Aburatani H
    Lung Cancer; 2012 Jan; 75(1):119-25. PubMed ID: 21737174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretome profiling identifies neuron-derived neurotrophic factor as a tumor-suppressive factor in lung cancer.
    Zhang Y; Wu X; Kai Y; Lee CH; Cheng F; Li Y; Zhuang Y; Ghaemmaghami J; Chuang KH; Liu Z; Meng Y; Keswani M; Gough NR; Wu X; Zhu W; Tzatsos A; Peng W; Seto E; Sotomayor EM; Zheng X
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31852841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.
    Maeda Y; Tsuchiya T; Hao H; Tompkins DH; Xu Y; Mucenski ML; Du L; Keiser AR; Fukazawa T; Naomoto Y; Nagayasu T; Whitsett JA
    J Clin Invest; 2012 Dec; 122(12):4388-400. PubMed ID: 23143308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.
    Gupta A; Wang Y; Browne C; Kim S; Case T; Paul M; Wills ML; Matusik RJ
    Prostate; 2008 Jan; 68(1):50-60. PubMed ID: 18004726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.